Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy–Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment-Reference-Cited by-同舟云学术

Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy–Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment

Published:2020-02-27 Issue:1 Volume:38 Page:145-162
ISSN:1029-8428
Container-title:Neurotoxicity Research
language:en
Short-container-title:Neurotox Res

Author:

Matta Célia,Meyer Laurence,Mensah-Nyagan Ayikoe-Guy^ORCID,Taleb Omar

Funder

Institut National de la Santé et de la Recherche Médicale

Centre National de la Recherche Scientifique

Université de Strasbourg

Association Ti'toine

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/s12640-020-00176-2.pdf

Reference93 articles.

1. Abrial SC, Penault-Llorca F, Delva R, Bougnoux P, Leduc B, Mouret-Reynier MA, Mery-Mignard D, Bleuse JP, Dauplat J, Cure H, Chollet P (2005) High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer. Breast Cancer Res Treat 94:255–263. https://doi.org/10.1007/s10549-005-9008-8

2. Argyriou AA, Kyritsis AP, Makatsoris T, Kalofonos HP (2014) Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature. Cancer Manag Res 6:135–147. https://doi.org/10.2147/CMAR.S44261

3. Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, Nurmikko T (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:1113–e1188. https://doi.org/10.1111/j.1468-1331.2010.02999.x

4. Berg A, Zelano J, Pekna M, Wilhelmsson U, Pekny M, Cullheim S (2013) Axonal regeneration after sciatic nerve lesion is delayed but complete in GFAP- and vimentin-deficient mice. PLoS One 8:e79395. https://doi.org/10.1371/journal.pone.0079395

5. Bigotte L, Olsson Y (1989) Distribution and toxic effects of intravenously injected epirubicin on the central nervous system of the mouse. Brain 112(Pt 2):457–469

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkin-mediated mitophagy is a potential treatment for oxaliplatin-induced peripheral neuropathy;American Journal of Physiology-Cell Physiology;2024-01-01

2. Therapeutic potential of progesterone in spinal cord injury‐induced neuropathic pain: At the crossroads between neuroinflammation and N‐methyl‐D ‐aspartate receptor;Journal of Neuroendocrinology;2022-08-04

3. The Effect of Schwann Cells/Schwann Cell-Like Cells on Cell Therapy for Peripheral Neuropathy;Frontiers in Cellular Neuroscience;2022-03-08

4. Neurosteroids and neuropathic pain: An up-to-date perspective;Current Opinion in Endocrine and Metabolic Research;2022-02

5. The α2,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development;Pharmacology Biochemistry and Behavior;2020-09